Court Upholds Convictions in Theranos Fraud Case
Source: abcnews.go.com Judicial Ruling on Theranos Executives A U.S. appellate court has upheld the convictions in the Theranos Fraud Case, involving the founder and president of the now-defunct blood-testing startup that once boasted a valuation of $9 billion. The ruling, delivered on Monday by a three-judge panel from the 9th U.S. Circuit Court of Appeals in San Francisco, affirmed the verdicts against both executives, rejecting claims of legal missteps during their respective trials. The decision marks a significant moment in a legal battle that has been ongoing since 2018 when both individuals were indicted on charges of defrauding investors. Their convictions, finalized in 2022, followed high-profile trials that detailed misleading claims about the company’s blood-testing technology and its potential to revolutionize healthcare diagnostics. The court’s ruling solidifies the accountability measures taken against corporate misconduct within the biotechnology sector. Background and L...